Fig. 7: Cells with mutations in CREBBP exhibit inhibition of histone acetylation following inhibition of CBP function.

a–c Histone acid extraction and immunoblot following A-485 (a), shCREBBP (b), or ICG-001 (c) in HNSCC cell lines of varying CREBBP and EP300 status.